Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
Conditions: Binge-Eating Disorder; Obesity Interventions: Drug: Naltrexone and Bupropion; Other: Placebo Sponsor: Yale University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Binge Eating Disorder | Bupropion | Eating Disorders & Weight Management | Obesity | Research | Wellbutrin